Advertisement

Topics

BioRexis Pharmaceutical Corporation Company Profile

18:33 EST 15th December 2018 | BioPortfolio

BioRexis™ develops and produces novel biopharmaceuticals with superior pharmacology using efficient manufacturing systems. Many biopharmaceuticals face difficulties in development and commercialization due to pharmacological issues. For example, many peptides that are currently approved or in development have a very short half-life, requiring both high and frequent dosing. Unwanted side effects from high peak levels can limit therapeutic benefit, and frequent trough low levels may narrow application of the particular product. High dosing per patient also places a further burden on already limited manufacturing capacity, driving up the cost of treatment, as in the case of monoclonal antibodies and other high-priced biopharmaceuticals.

Location

3400 Horizon Drive
King of Prussia
Pennsylvania
19406
United States of America

Contact

Phone: (610) 313-4000
Fax: (610) 313-4039
Email: info@biorexis.com.


News Articles [287 Associated News Articles listed on BioPortfolio]

Orion Corporation's financial reporting and Annual General Meeting in 2019

ORION CORPORATION          STOCK EXCHANGE RELEASE           18 JULY 2018 at 11.00 EEST                       Orion Corporation's fina...

Orion acquires sales and distribution rights for certain European Countries for Parkinson's disease drug Stalevo

ORION CORPORATION              PRESS RELEASE           4 DECEMBER  2018 at 15.00 EET Orion acquires sales and distribution rights for certa...

Ambu A/S: Articles of Association November 2018

  Attached the updated Articles of Association November 2018 Complete Articles of Association November 2018This announcement is distributed by West Corporation on behalf of West Corporation...

Ambu A/S: Articles of Association December 2018

  Attached Complete Articles of Association December 2018 Complete Articles of Association December 2018This announcement is distributed by West Corporation on behalf of West Corporation cl...

Orion Corporation: Managers' transactions - Anne Karvonen

ORION CORPORATION      MANAGERS' TRANSACTIONS 20 June 2018 at 11.45 EEST Orion Corporation: Managers' transactions - Anne Karvonen Orion Corporation has received the fo...

Orion Corporation: Managers' transactions - Nina Karvonen

ORION CORPORATION         MANAGERS' TRANSACTIONS 20 June 2018 at 12.00 EEST Orion Corporation: Managers' transactions - Nina Karvonen Orion Corporation has recei...

Publishing of Orion Corporation's Half-Year Financial Report for January-June 2018 on 18 July 2018

ORION CORPORATION                     PRESS RELEASE                   5 JULY 2018 at 11.30 EEST Publishing of Orion Corporation's H...

Mandatory notification of trade

Valborg Godal Vold, COO of Vistin Pharma ASA, and a primary insider, has on 18 September 2018 sold 50,000 shares in Vistin Pharma ASA at an average price of NOK 10.58 per share. Following this sa...

PubMed Articles [502 Associated PubMed Articles listed on BioPortfolio]

Projecting Pharmaceutical Expenditure in EU5 to 2021: Adjusting for the Impact of Discounts and Rebates.

Within (European) healthcare systems, the predominant goal for pharmaceutical expenditure is cost containment. This is due to a general belief among healthcare policy makers that pharmaceutical expend...

Applications of various analytical techniques in quality control of pharmaceutical excipients.

Although excipients are pharmacologically inert substances, still they are integral and significant ingredients of a pharmaceutical formulation. Their amount and concentration level along with the act...

Applications of proteomics in pharmaceutical research and development.

The significance of proteomics in the pharmaceutical industry has increased since overcoming initial difficulties. This review discusses recent proteomics publications from pharmaceutical companies to...

Solid-state insight into the action of a pharmaceutical solvate: structural, thermal and dissolution analysis of indinavir sulfate ethanolate.

The crystal structure of indinavir sulfate, a pharmaceutical administered as an ethanol solvate, is presented, revealing a unique channel/ionic solvate structure to be characteristic of the compound. ...

Comparison of Rheological and Sedimentation Behavior of Commercially Available Suspending Vehicles for Oral Pharmaceutical Preparations.

A pharmaceutical suspension is a semi-liquid dosage form suitable for patients being unable to swallow solid medicines such as tablets and capsules. A vehicle used for the preparation of pharmaceutica...

Clinical Trials [332 Associated Clinical Trials listed on BioPortfolio]

Clinical Impact of Pharmaceutical Consultations in Patients Treated for Chronic Obstructive Pulmonary Disease at Home

The implementation of pharmaceutical consultations in the city or at the hospital could modify the occurrence of exacerbations related to chronic obstructive pulmonary disease after return...

Pharmaceutical Care for Asthma Control Improvement (PHARMACI)-Study

The objective of this study is to evaluate the therapeutic effectiveness and cost-effectivity of pharmaceutical care for asthma patients.

Pharmaceutical Care for Diabetes Type 2 Patients: a Randomised Controlled Trial

The objective of this study is to evaluate the therapeutic effectiveness and cost-effectivity of pharmaceutical care for diabetes type 2 patients. Patients will be randomly allocated to th...

Improving Compliance Among Elderly Polypharmacy Users Through Community Pharmacy Based Pharmaceutical Care Program

The aim of the project is to evaluate effectiveness of a multidimensional pharmaceutical care plan in improving compliance among elderly polypharmacy users at community pharmacy settings. ...

Impact of Collaborative Pharmaceutical Care on Hospital Admission Drug Prescriptions for Patients 65 Years of Age and Older

The primary objective of this study is to evaluate the impact of the implementation of collaborative pharmaceutical care on drug support at admission for patients 65 years of age and older...

Companies [1234 Associated Companies listed on BioPortfolio]

BioRexis Pharmaceutical Corporation

BioRexis™ develops and produces novel biopharmaceuticals with superior pharmacology using efficient manufacturing systems. Many biopharmaceuticals face difficulties in development and commercializat...

Toshiba Corporation

Toshiba Medical Systems Corporation is a leading worldwide provider of medical diagnostic imaging systems and comprehensive medical solutions, such as CT, X-ray and vascular, ultr...

Bruker Daltonics

Bruker Corporation is a leading provider of high-performance scientific instruments and solutions for molecular and materials research, as well as for industrial and applied analy...

Oriola

Oriola is a part of Oriola-KD Corporation that was formed as a result of demerge of Orion Corporation on 1st of July 2006. The company is listed in the Helsinki Stock Exchange since 3rd of July 2006. ...

One Eleven Corporation

One Eleven Corporation is a leader in the development of digital solutions for healthcare professionals. For the past 16 years, One Eleven has proven that healthcare professionals...

More Information about "BioRexis Pharmaceutical Corporation" on BioPortfolio

We have published hundreds of BioRexis Pharmaceutical Corporation news stories on BioPortfolio along with dozens of BioRexis Pharmaceutical Corporation Clinical Trials and PubMed Articles about BioRexis Pharmaceutical Corporation for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of BioRexis Pharmaceutical Corporation Companies in our database. You can also find out about relevant BioRexis Pharmaceutical Corporation Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record